Ikarian Capital »

Proqr Thrapeutics N V shs euro shares owned by Ikarian Capital

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $936k 473k 1.98
2023-09-30 $614k 473k 1.30
2023-06-30 $766k 473k 1.62
2023-03-31 $1.0M 473k 2.13
2022-12-31 $1.6M 423k 3.70

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Proqr Thrapeutics N V shs euro

Privium Fund Management B.V.
EcoR1 Capital
M28 Capital Management
DAFNA Capital Management
Ikarian Capital
Millennium Management
Deutsche Bank Aktiengesellschaft
Monaco Asset Management SAM
Two Sigma Advisers
Franklin Street Advisors
Squarepoint Ops
Citadel Advisors
Two Sigma Investments
Bank of America Corporation
Bnp Paribas Arbitrage, Snc

View all funds holding Proqr Thrapeutics N V shs euro